Intelligent Bio Solutions (INBS) announced it has expanded access to its fingerprint drug testing in Spain and Andorra through a strategic collaboration with Detecto, a division of Spanish distributor MTB Distribuciones Tecnologicas SL. MTB established Detecto following decades of experience in clinical distribution, recognizing the market’s evolving needs and increasing demand for drug testing across various sectors. Detecto is now a leading provider of drug testing solutions throughout Spain and Andorra. INBS’ partnership with Detecto aims to leverage the strengths of both companies and expand access to fingerprint sweat-based drug testing across various sectors, including workplace safety and transportation.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INBS:
- Intelligent Bio Solutions Secures U.S. Patent for Drug Screening
- Intelligent Bio Solutions secures U.S. patent, strengthening IP protection
- Intelligent Bio FDA clearance process remains on track for 2025 U.S. launch
- Intelligent Bio Solutions Anticipates Sixth U.S. Patent Approval
- Intelligent Bio Solutions expects to receive sixth patent in the U.S.